- Home
- FC vs IVVD Comparison
FC vs IVVD Comparison
Compare FC & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FC | IVVD |
|---|---|---|
| Founded | 1983 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.8M | 212.6M |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | FC | IVVD |
|---|---|---|
| Price | $17.58 | $0.64 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $31.00 | $10.00 |
| AVG Volume (30 Days) | 39.6K | ★ 4.1M |
| Earning Date | 11-04-2026 | 11-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 79.02 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $267,067,000.00 | $53,426,000.00 |
| Revenue This Year | N/A | $12.40 |
| Revenue Next Year | $4.19 | $44.85 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 110.47 |
| 52 Week Low | $11.16 | $0.53 |
| 52 Week High | $26.81 | $3.07 |
Technical Indicators
Market Signals| Indicator | FC | IVVD |
|---|---|---|
| Relative Strength Index (RSI) | 37.44 | 37.55 |
| Support Level | $16.37 | $0.53 |
| Resistance Level | $19.17 | $1.02 |
| Average True Range (ATR) | 0.72 | 0.06 |
| MACD | -0.09 | 0.00 |
| Stochastic Oscillator | 14.57 | 28.85 |
Price Performance
Historical ComparisonAbout FC Franklin Covey Company
Franklin Covey Co is a company focused on organizational performance improvement. It operates in the business segments of North America, International Direct Offices, International Licensees, Education Division. The company derives revenue from providing training and consulting services and through the sale of books, audio media, and other related products. It has a business presence in Australia, New Zealand, China, Japan, the United Kingdom, Ireland, and Other countries.
About IVVD Invivyd Inc.
Invivyd Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of monoclonal antibody (mAb) therapies for the prevention and treatment of serious viral infectious diseases. Its lead product, PEMGARDA (pemivibart), received emergency use authorization from the U.S. FDA for the pre-exposure prevention of COVID-19 in certain immunocompromised individuals. The company is also developing next-generation antibody candidates, including VYD2311 for COVID-19 and VBY329 for RSV infections, while continuing research on additional antibodies targeting other viral diseases such as measles.